Contact:

Jill Johnson
Office of the Associate Director
Developmental Therapeutics Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
EPN, Room 8020
Ph: 301-496-8720
e-mail: johnsoji@mail.nih.gov

Objective of Project:

The Developmental Therapeutics Program (DTP), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI) invites academic cancer researchers to form partnerships among academia, industry, non-profit institutions, and government entities to conduct novel cancer therapeutic, prevention, diagnostic, and imaging intervention-directed research. The research should take advantage of the latest discovery and development technologies and focus on "orphan" cancers or biologically defined subsets of more common tumor types, using a multidisciplinary approach. The research will occur at the academic center with the advice and support of industrial, non-profit institute, and government partners and the NCI. NCI anticipates that selected research projects will be of great interest to the cancer research community as a whole and may be initiated as basic research projects. The goal of the research is to generate novel interventions for human clinical trials

Description of Project:

The purpose of the Academic Public Private Partnership Program (AP4) is to create partnerships between academia, industry, non-profit institutions, and government to stimulate novel cancer therapeutic, prevention, diagnostic, and imaging intervention-directed research which takes advantage of the latest discovery and development technologies with a focus on orphan diseases, using a multidisciplinary approach. By bringing together the necessary expertise to discover and develop novel cancer interventions, the AP4 initiative will shorten the time required to bring these critical new therapeutic agents, preventive, diagnostic and imaging agents to clinical trials.